Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant

• Status: Withdrawn
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a study of patients who have a high risk of kidney rejection before kidney transplant. The hypothesis is that treatment with a medication called rituximab will make it possible for them to receive a kidney transplant from a donor who previously did not present a good match.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Wisconsin, Madison
• Collaborator: Genentech, Inc.
• Treatments: Rituximab

Criteria

Inclusion Criteria:

• Active status on a kidney transplant waiting list with positive cross match against a living donor

Exclusion Criteria:

• Receipt of a live vaccine within 4 weeks prior to randomization

• Previous Treatment with Rituximab